StonvexLoading…
StonvexStonvexStonvexCore line items from KAYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $7.13K | $196.29K | $685.38K | $889.90K |
Operating Income | $-2.02M | $-1.02M | $-1.71M | $-1.43M |
Net Income | $-2.08M | $1.61M | $-3.58M | $9.72M |
EPS (Diluted) | $-0.07 | $0.01 | Not available | Not available |
Total Assets | $216.37K | $215.86K | $843.24K | $1.57M |
Total Liabilities | $17.34M | $15.97M | $18.45M | $15.98M |
Cash & Equivalents | $39.67K | $29.11K | $18.33K | $565.98K |
Free Cash Flow OCF − CapEx | $-857.96K | Not available | Not available | $-1.06M |
Shares Outstanding | 41.46M | 22.16M | 22.17M | 14.72M |